SNSS · Categories · Form 3
SNSS - SEC Form 3 initial insider statements
Sunesis Pharmaceuticals, Inc. (SNSS) sec form 3 initial insider statements - real-time wire coverage filtered to Form 3 only.
Recent Form 3 for SNSS
- SEC Form 3 filed by J. Barry Simon3 - Viracta Therapeutics, Inc. (0001061027) (Issuer)
- SEC Form 3 filed by Stephen Rubino3 - Viracta Therapeutics, Inc. (0001061027) (Issuer)
- SEC Form 3: Partnership Limited Fund 2 Amoon claimed ownership of 7,392,237 units of Common Stock3 - SUNESIS PHARMACEUTICALS INC (0001061027) (Issuer)
- SEC Form 3: Gur Roshwalb claimed ownership of 7,392,237 units of Common Stock3 - SUNESIS PHARMACEUTICALS INC (0001061027) (Issuer)
- SEC Form 3: R. Daniel Chevallard claimed ownership of 44,760 units of Common Stock3 - SUNESIS PHARMACEUTICALS INC (0001061027) (Issuer)
- SEC Form 3 filed by E Thomas Darcy3 - SUNESIS PHARMACEUTICALS INC (0001061027) (Issuer)
- SEC Form 3 filed by Michael Huang3 - SUNESIS PHARMACEUTICALS INC (0001061027) (Issuer)
- SEC Form 3 filed by Lafayette Samuel Murphy3 - SUNESIS PHARMACEUTICALS INC (0001061027) (Issuer)
- SEC Form 3 filed by Roger Pomerantz3 - SUNESIS PHARMACEUTICALS INC (0001061027) (Issuer)
- SEC Form 3 filed by Lisa Rojkjaer3 - SUNESIS PHARMACEUTICALS INC (0001061027) (Issuer)
- SEC Form 3: Ivor Royston claimed ownership of 559,198 units of Common Stock3 - SUNESIS PHARMACEUTICALS INC (0001061027) (Issuer)